W
WAVEMAN · COMPANY
ISRG · Intuitive Surgical Inc
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+2.47% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET-4.47% 13F +710MSTR-1.35% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

ISRG

INTUITIVE SURGICAL INC
MEDICAL DEVICES · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · CIK 0001035267
CONGRESS · 1FORM 144 · 3☆ WATCH
INSIDER NET · 180D
-$8.0M
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
0
CONGRESS BUYERS · 1Y
1
FUNDS ADDED · QTR
1,083
13F, latest reported quarter
REVENUE GROWTH
+20.5%
XBRL, annual
NET MARGIN
28.4%
CONVERSIONS · 180D
13
codes C/M, not in net · $457.2K priced
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net -$8.0M over 180 days
-$4.7M over 90 days
below 81% of Medical Devices
CONGRESS
1 member bought in the last year
the lowest in Medical Devices
FUNDS
1,083 funds added or opened last quarter
more than 99% of Medical Devices
REVENUE
+20.5% year over year
more than 77% of Medical Devices
MARGIN
28.4% net margin
more than 97% of Medical Devices
BUYBACKS
$1.4B repurchased, FY to 2026-06-30
more than 94% of Medical Devices
SHORT
1.9% of shares outstanding short · 1.4 days to cover · settled 2026-07-31
below 65% of Medical Devices
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
Insiders are net sellers: -$8.0M across 6 people in 180 days.
1,083 funds added or opened positions in the latest 13F quarter, of 2,256 holders.
1 member of Congress reported buying it this year.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -20.7%
-20.7%12M
-29%-11%+8%+26%2025-092025-102025-122026-032026-052026-072026-09 2025-10-24 · GUTHART GARY S sold $15.8M2025-10-24 · Rosa David J. sold $13.4M2025-12-01 · GUTHART GARY S sold $13.0M2026-01-27 · GUTHART GARY S sold $13.0M2026-08-11 · GUTHART GARY S sold $4.0M2025-10-28 · Curet Myriam sold $2.8M2025-11-12 · Charlton Henry L sold $2.7M2025-12-12 · Brosius Mark sold $2.5M2026-06-01 · Jeddi Iman sold $2.4M2026-03-03 · Curet Myriam sold $2.3M2025-11-12 · Charlton Henry L sold $1.7M2025-11-12 · Charlton Henry L sold $1.7M2025-11-12 · Charlton Henry L sold $1.5M2025-11-10 · Miller Brian Edward sold $1.3M2025-10-24 · BARRATT CRAIG H sold $1.2M2026-03-04 · Brosius Mark sold $1.2M2026-02-27 · Curet Myriam sold $1.2M2025-11-05 · Widman Fredrik sold $1.0M2025-10-24 · GUTHART GARY S sold $764.9K2025-10-24 · GUTHART GARY S sold $764.7K2025-10-28 · Curet Myriam sold $756.3K2025-11-10 · Miller Brian Edward sold $746.4K2026-01-27 · GUTHART GARY S sold $744.1K2026-01-27 · GUTHART GARY S sold $744.1K2025-10-28 · Curet Myriam sold $632.3K2025-11-12 · BARRATT CRAIG H sold $435.0K2025-11-12 · Charlton Henry L sold $368.9K2026-03-05 · Brosius Mark sold $320.9K2026-03-06 · Brosius Mark sold $317.6K2026-03-03 · Brosius Mark sold $316.3K2026-03-09 · Brosius Mark sold $312.8K2025-12-15 · Brosius Mark sold $254.5K2025-12-15 · Brosius Mark sold $254.5K2026-04-28 · Ladd Amy L sold $236.7K2026-02-11 · Curet Myriam sold $208.4K2026-05-11 · LOEB GARY sold $178.8K2025-12-12 · Brosius Mark sold $170.8K2026-06-10 · LOEB GARY sold $169.7K2025-09-03 · Ladd Amy L sold $158.0K2026-08-10 · LOEB GARY sold $151.6K2026-08-10 · Ladd Amy L sold $151.6K2025-09-04 · Ladd Amy L sold $147.6K2026-08-11 · GUTHART FAMILY TRUST filed to sell $7.9M2026-08-10 · GARY LOEB filed to sell $151.5K2026-08-10 · AMY L LADD filed to sell $178.8K
INSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
Insiders have filed to sell — before selling.
The record shows a net $8.0M sold by insiders over 180 days, 1,083 funds added last quarter, 1 Congress member(s) bought in 12 months, $8.2M in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
TMOPENROKBLFSMTDSIBNWRBYTXGDXCMEWTMDXOM
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, INTUITIVE SURGICAL INC insiders sold a net $8.0M of stock across 407 Form 4 purchases and sales, with 0 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Brosius Mark
EVP & Chief Mfg and Supply Cha
SELL
2026-08-21
77.0
$28.9K
Brosius Mark
EVP & Chief Mfg and Supply Cha
SELL
2026-08-20
77.0
$30.5K
Brosius Mark
EVP & Chief Mfg and Supply Cha
SELL
2026-08-19
77.0
$30.4K
Brosius Mark
EVP & Chief Mfg and Supply Cha
SELL
2026-08-18
77.0
$30.3K
Brosius Mark
EVP & Chief Mfg and Supply Cha
SELL
2026-08-17
77.0
$30.1K
407 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 402 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
BlackRock, Inc.
30,024,648.0 sh
$11.9B
VANGUARD CAPITAL MANAGEMENT LLC
23,131,099.0 sh
$9.2B
STATE STREET CORP
16,063,040.0 sh
$6.4B
Invesco Ltd.
11,843,563.0 sh
$4.7B
GEODE CAPITAL MANAGEMENT, LLC
8,534,767.0 sh
$3.4B
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
GUTHART FAMILY TRUST
FILED 2026-08-11
$7.9M
GARY LOEB
FILED 2026-08-10
$151.5K
AMY L LADD
FILED 2026-08-10
$178.8K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
iShares U.S. Medical Devices ETF
$494.1M POSITION · AS OF 2026-03-31
15.6%
Biondo Focus Fund
$6.2M POSITION · AS OF 2026-03-31
14.2%
Select Medical Technology and Devices Portfolio
$317.2M POSITION · AS OF 2026-02-28
8.7%
Global X Robotics & Artificial Intelligence ETF
$205.3M POSITION · AS OF 2026-02-28
5.8%
INVESTMENT HOUSE GROWTH FUND (THE)
$12.4M POSITION · AS OF 2026-04-30
5.5%
Neuberger Disrupters ETF
$1.4M POSITION · AS OF 2026-02-28
5.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 46 registered trials, 17 still enrolling or running — a status change here is dated weeks before the press release
2
Phase 2
0 ACTIVE
2
Phase 3
1 ACTIVE
1
Phase 4
1 ACTIVE
41
Not applicable
15 ACTIVE
What changed recently
A Randomized Controlled Trial Comparing Percutaneous CT-Guided Biopsy and Shape-Sensing
2026-09-03 · Not Yet Recruiting → Recruiting
Phase 4
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Corporate PAC
FEC · the company-connected political action committee's own receipts and spending — committee totals only, never individual donors
Intuitive Surgical Inc Pac
CYCLE 2026 · $0K SPENT
$0
FEDERAL ELECTION COMMISSION · MATCHED BY THE PAC'S CONNECTED ORGANISATION
Executive pay vs shareholder return · Gary S. Guthart, Ph.D.
DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself
FY
CEO TOTAL
ACTUALLY PAID
OTHER NEOs AVG
TSR
PEER TSR
2020
$6.0M
$15.0M
$3.5M
+38%
+33%
TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
REVENUE$10.1B$8.4B$7.1B$6.2B
GROSS PROFIT$6.6B$5.6B$4.7B$4.2B
OPERATING INCOME$2.9B$2.3B$1.8B$1.6B
NET INCOME$2.9B$2.3B$1.8B$1.3B
EPS (DILUTED)7.876.425.033.65
OPERATING CASH FLOW$3.0B$2.4B$1.8B$1.5B
CASH$3.4B$2.0B$2.8B$1.6B
BUYBACKS$2.3B$0$416.3M$2.6B
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →